Unveiling the Bioactive Potential of Shilajit: Integrated Chemical Profiling and Antimicrobial Evaluation via Chromatographic, Spectroscopic, and In Silico Approaches
Abstract
Shilajit is a herbomineral exudate widely used in traditional medicine and composed mainly of humic substances and low‐molecular‐weight organic constituents. However, the chemical composition and biological relevance of its low‐molecular‐weight fraction remain poorly understood. In this study, sequential fractionation was employed to obtain humins (HM), humic acid (HA), fulvic acid (FA), and a low‐molecular‐weight residual fraction (RF). FTIR analysis supported successful fractionation, with HA and FA exhibiting characteristic humic‐like functional groups, while the RF showed reduced polymeric features consistent with enrichment in smaller organic molecules. Comprehensive chemical profiling using multi‐solvent GC‐MS following derivatization enabled the detection of structurally diverse metabolites. The RF exhibited a broader metabolite profile than whole Shilajit, with 36 low‐molecular‐weight compounds tentatively identified, including phenolics, aromatic acids, esters, flavanol derivatives, and sterol‐related compounds. SEM‐EDS analysis revealed heterogeneous morphology and elemental composition. In silico ADMET predictions suggested favorable gastrointestinal absorption and low predicted toxicity for most compounds. Antimicrobial assays demonstrated stronger antibacterial activity of the RF compared to whole Shilajit, while antifungal activity remained limited. Overall, the findings highlight the biological significance of low‐molecular‐weight constituents in Shilajit.
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.